Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Department of Pharmacology is delighted to announce the appointment of Sir Jonathan Symonds CBE, Chair of the Board of GlaxoSmithKline, as a Visiting Fellow. Jon has been Chairman of the Board at GSK since September 2019.

Sir Jon Symonds

Announcing the appointment, the Head of the Department of Pharmacology, Professor Fran Platt, said, “Jon is a perfect fit with our aspirations as a department, to form meaningful partnerships with industry to build on our fundamental research and to maximise translation of our discoveries.”

Jon has extensive international financial, life sciences and governance experience. In July 2021, Jon co-chaired with Professor Sir John Bell the preparation of the UK Life Science Vision, which sets out a strategy for UK life sciences in the post-Covid world and seeks to capitalise on many of the UK’s scientific successes through the pandemic.

Read the full story on the Department of Pharmacology website

Similar stories

Anant Parekh to deliver The Physiological Society's Annual Review Prize Lecture

The Annual Review Prize Lecture is The Physiological Society's most prestigious lecture.

Professor Sir Andrew Pollard Awarded the James Spence Medal in 2022

Professor Sir Andrew Pollard, BSc MA MBBS MRCP(UK) FRCPCH PhD DIC FHEA FIDSA FMedSci, is Professor of Paediatric Infection and Immunity at the University of Oxford, Honorary Consultant Paediatrician at Oxford Children’s Hospital and Vice Master of St Cross College, Oxford.

Department of Paediatrics celebrates 50-year anniversary

After being established in 1972, the Department of Paediatrics' contributions have spanned teaching, innovation, and research. The department also builds upon a longer lineage in Oxford that has impacted child health.

COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds

Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.

PhD Student of the Year 2022 Winner!

Congratulations to Nuffield Department of Women's & Reproductive Health DPhil student Josephine Agyeman-Duah on being named winner of PhD Student of the Year at the Postgrad Awards 2022.